Project Description
IFC proposes to support the expansion of NPF Helix, a privately held independent chain of in-vitro diagnostic (IVD) medical laboratories. The Company offers a wide variety of tests including clinical, chemistry, coagulation, immuno-chemistry, microbiology and molecular diagnostic. Helix has a strong emphasis on quality, including certification and audit by outside parties. In addition to Russian quality certifications for diagnostic laboratories, the company has ISO 9001:2008 certification. The project entails expansion of the existing laboratories in St. Petersburg and Yekaterinburg, establishment of a new laboratory in Moscow and widening the Company network of diagnostic centers and sample collection points (the “Project”).